Characteristics of health-related quality of life and related factors in patients with brain tumors treated with rehabilitation therapy

Background Rehabilitation therapy during hospitalization is effective in improving activities of daily living (ADL) and physical function in patients with brain tumors. However, there are few studies on the effect of rehabilitation therapy on health-related quality of life (HRQOL) in patients with brain tumors. Additionally, the EuroQol-5Dimension-5Level (EQ-5D-5L) index score has not been reported as an outcome. This study aimed to investigate the HRQOL of patients with brain tumors who underwent rehabilitation therapy and investigated the factors affecting the EQ-5D-5L index score from various perspectives, including various brain tumor types, treatment methods, and recurrence. In addition, we examined the relationship between the EQ-5D-5L index score, disease-specific HRQOL scale, and ADL. Methods Patients with brain tumors who underwent treatment and rehabilitation at Niigata University Medical & Dental Hospital were included in this cross-sectional study. We used the EQ-5D-5L, European Organisation for Research and Treatment of Cancer (EORTC) quality of life questionnaire core 30, and EORTC quality of life questionnaire brain cancer module to evaluate HRQOL. ADL were assessed using the functional independence measure (FIM). The relationship between each HRQOL assessment score and the FIM was analyzed, and the influence of related factors was assessed by multiple regression analysis. Results This study included 76 patients. The EQ-5D-5L index score was 0.689 for all patients with brain tumors and 0.574 for those with glioblastomas, which was the lowest value. There was a strong correlation between the EQ-5D-5L index score and FIM (r = 0.627, p<0.001). Multiple regression analysis revealed that glioblastoma histology (coefficient: -0.570, p = 0.024) and surgery (coefficient: 0.376, p = 0.030) were independent factors affecting the EQ-5D-5L index score. Conclusions Patients with glioblastoma undergoing rehabilitation may have reduced HRQOL, which was influenced by glioblastoma histology and surgery.


FIM
The FIM is an assessment of ADL, consisting of a motor category for self-care tasks 160 (eating, grooming, bathing, dressing, toileting), sphincter control tasks (bladder 161 management, bowel management), transfer tasks (bed-to-chair transfer, toilet transfer, 162 tub or shower transfer), and locomotion tasks (walk or wheelchair, stairs), and a . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022 163 cognitive category for communication tasks (comprehension, expression) and social 164 cognition tasks (social interaction, problem solving, memory). Each task is scored on 165 a scale of 1 to 7 according to the level of independence, with 1 representing complete 166 assistance and 7 representing complete independence. The total score ranges from 18 167 to 126, with a higher score indicating a greater degree of independence.

QLQ-C30 and BN20
170 In this study, QLQ-C30 Japanese version (3rd edition) and BN20 were used for 171 evaluation. These are the HRQOL questionnaires developed by the EORTC, which 172 have been reported to be valid and reliable [4,5]. The QLQ-C30 is a disease-specific 173 HRQOL assessment scale for patients with cancer. It consists of five functional 174 scales (physical, role, cognitive, emotional functioning, and social functioning), nine 175 symptom scales (nausea and vomiting, fatigue, dyspnea, pain, insomnia, appetite loss, 176 constipation, diarrhea, and financial difficulties), and global health status.
177 The BN20 is a disease-specific measure of brain tumor symptoms. The BN20 is 178 divided into the following symptom scales: future uncertainty, visual disorder, motor 179 dysfunction, communication deficit, headache, seizure, drowsiness, hair loss, itchy 180 skin, weakness of legs, and loss of bladder control.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022 181 The use of the above rating scales was approved by the EORTC Quality of Life 182 Group. The QLQ-C30 and BN20 subscales are scored from 0 to 100 according to the 183 scoring manual. A higher score on the QLQ-C30 functional scale and general health 184 indicates better health, while a lower score on the QLQ-C30 symptom scale and 185 BN20 indicates fewer complaints or better health.

EQ-5D-5L
188 The EQ-5D-5L is a generic preference-based measure of HRQOL developed by the 189 EuroQol Group. EQ-5D-5L consists of five dimensions related to mobility, self-care, 190 common activities, pain/discomfort, and anxiety/depression. Patients answer each 191 item on a scale of 1 to 5 (no problems, slight problems, moderate problems, severe 192 problems, and extreme problems). Initially developed by the EuroQol Group in 1987, 193 the EuroQol-5Dimension-3Level (EQ-5D-3L) index was a five-item, three-level 194 instrument. However, its sensitivity was insufficient, and a ceiling effect was 195 identified. As a result, the five-level EQ-5D-5L was released to overcome these 196 shortcomings [25]. In Japan, the EQ-5D-5L conversion table was completed in 2015, 197 and the EQ-5D-5L index score reflecting Japanese values can be calculated [6]. The 198 EQ -5D-5L utility index ranges from -0.025 to 1.00 (full health status).
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 28, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022 210 "moderately correlated", and 0.7-1.0 as "strongly correlated". Finally, a multiple 211 regression analysis was performed to investigate the factors affecting the EQ-5D-5L 212 index score at the time of hospital discharge, with the EQ-5D-5L index score as the 213 dependent variable and age, sex, brain tumor type, surgery, radiotherapy, 214 chemotherapy, and newly diagnosed or recurrent disease as independent variables. In 215 this study, the forced imputation method of analysis was used to visually compare all 216 independent variables with one other. The independent variables were selected with . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 28, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022 217 reference to previous studies that used the HRQOL scale and FIM total score as 218 independent variables [15,27]. Categorical data were transformed into dummy 219 variables, and WHO grade I was used as the reference category for brain tumor type. 220 A P-value of <0.05 was regarded as being statistically significant, and all reported 221 P-values were two-tailed. All statistical procedures were conducted using SPSS for is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 28, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022  Comparison of assessment scores among brain tumor types 239 The assessment scores are summarized in Table 2. The FIM total score and KPS did 240 not differ significantly among the brain tumor types. In contrast, the EQ-5D-5L 241 index score (p = 0.048), emotional functioning (p = 0.015), financial difficulties (p = 242 0.002), and future uncertainty (p = 0.014) significantly differed among the groups.

243
The EQ-5D-5L index score for all patients was 0.689±0.205. The glioblastoma group . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022 244 received the lowest score (0.574±0.229) and the WHO grade I group received the 245 highest score (0.762±0.135). In addition, the glioblastoma group received the lowest 246 score for emotional functioning and the highest scores for financial difficulties and 247 future uncertainty among all groups. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022.  Table 3. The role functioning score was 253 significantly higher (p = 0.027) and the scores for fatigue (p = 0.030), future 254 uncertainty (p = 0.025), and weakness of legs (p = 0.020) were significantly lower in 255 the group that underwent surgery than in the group that did not undergo surgery. The 256 score for headache (p = 0.006) was significantly lower and the scores for hair loss (p 257 = 0.001) and itchy skin (p = 0.002) were significantly higher in the group that 258 received radiotherapy than in the group that did not receive radiotherapy. The 259 EQ-5D-5L index (p = 0.029), emotional functioning (p = 0.027), and visual disorder 260 (p = 0.038) scores were significantly lower and the financial difficulties (p = 0.013), 261 future uncertainty (p = 0.044), hair loss (p = 0.018), and itchy skin (p = 0.002) scores 262 were significantly higher in the group that received chemotherapy than in the group 263 that did not receive chemotherapy. The KPS (p = 0.009), FIM total score (p = 0.048), 264 EQ-5D-5L index score (p = 0.016), physical functioning score (p = 0.004), and role 265 functioning score (p = 0.032) were significantly lower and the fatigue (p = 0.002), . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

269
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022. ; https://doi.org/10.1101/2022.04.25.22274293 doi: medRxiv preprint 271 Correlations among the EQ-5D-5L index score, FIM, and 272 disease-specific HRQOL scale 273 The correlations among the EQ-5D-5L index score, FIM, and disease-specific 274 HRQOL scale are shown in Table 4. There was a strong correlation between the 275 EQ-5D-5L index score and FIM (r = 0.627, p<0.001). Furthermore, the EQ-5D-5L 276 index score and the disease-specific HRQOL scale showed significant correlations 277 for all items with the exception of headache, hair loss, and itchy skin. In particular, 278 strong correlations were observed with physical functioning (r = 0.723, p<0.001). In 279 contrast, only physical functioning (r = 0.610, p<0.001) and dyspnea (r = -0.433, 280 p<0.001) showed more than a moderate correlation between FIM and the 281 disease-specific HRQOL measure.

282
283 Multiple regression analysis for 5EQ-5D-5L index score 284 Multiple regression analysis was performed on the 5EQ-5D-5L index score, with age, 285 sex, brain tumor type, surgery, radiotherapy, chemotherapy, and first occurrence or 286 recurrence as independent variables (Table 5). Glioblastoma (standard partial 287 regression coefficient: -0.570, p = 0.024) and surgery (standard partial regression 288 coefficient: 0.376, p = 0.030) were identified as factors affecting the EQ-5D-5L 289 index score. This study aimed to investigate the effects of brain tumor type, recurrence, and 294 treatment on the EQ-5D-5L index score and to clarify the characteristics of HRQOL 295 in different brain tumor types and its relationship with ADL.

296
The mean EQ-5D-5L index score at the time of hospital discharge for all patients 297 with brain tumors in this study was 0.689±0.205 (mean age 61.1 years). The WHO 298 grade I group had the highest score of 0.762±0.135 (mean age 61.8 years) and the 299 glioblastoma group had the lowest score of 0.574±0.229 (mean age 58.7 years). In . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022. ; https://doi.org/10.1101/2022.04.25.22274293 doi: medRxiv preprint 300 Japan, the EQ-5D-5L index score for patients with brain tumors has not been 301 reported previously, and in other countries, Wagner et al [7] reported a mean index 302 score of 0.72 in 3-month postoperative patients with benign meningiomas. The 303 EQ-5D-5L index score of the WHO grade I group in this study was comparable, 304 although simple comparison is difficult because the EQ-5D-5L index score is 305 calculated using a country-specific conversion table. However, the mean EQ-5D-5L 306 index score of the general population in Japan was reported to be 0.936 in the 50s 307 and 0.911 in the 60s [28]. In the case of patients with various types of outpatient 308 cancers aside from brain tumors, the reported value was 0.827 [29]. In addition, the 309 mean score was 0.52 (mean age 57 years) in stroke patients, who are expected to 310 present with similar functional impairment [30]. The EQ-5D-5L index score of the 311 brain tumor patients in this study was lower than that of the general population and 312 patients with other cancers, although the results should be interpreted with caution 313 regarding the different effects of the time of assessment, age, and disease.
314 Furthermore, the values were similar between the current glioblastoma group and 315 previous reports of stroke. In the present study, there were significant differences in 316 emotional functioning, financial difficulties, and future uncertainty among brain 317 tumor types. In addition, the glioblastoma group showed the lowest values for all . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022. ; https://doi.org/10.1101/2022.04.25.22274293 doi: medRxiv preprint 318 scales. Budrukkar et al [22] reported that the Global Health Status of the QLQ-C30 319 was significantly lower in the high-grade glioma (HGG) group than in the low-grade 320 glioma (LGG) group. In a study of glioma patients treated with rehabilitation therapy 321 during hospitalization, Umezaki et al [27] found that the HGG group had fewer 322 complaints of QLQ-C30 constipation and more complaints of BN-20 hair loss and 323 itchy skin than did the LGG group. These previous studies and the current results 324 differed in the items that showed significant differences. This may have been due to 325 the differences in the brain tumor type and the individuality of the hospitals in the 326 study area. However, it is interesting to note that in the present study, the scores of

327
the HRQOL items reflecting psychological aspects were lower in the glioblastoma 328 group than in the other groups. Glioblastomas carry a poorer prognosis than other 329 brain tumors, aside from MBTs, and may cause psychological problems. Indeed, 330 patients with glioblastoma have been reported to have more depressive symptoms 331 than patients with gastric, urological, breast, and lung cancers [31]. Further, most 332 brain tumors classified as WHO grade I can be treated with surgery alone, but brain 333 tumors classified as WHO grade II or higher often require radiation therapy or 334 chemotherapy in addition to surgery. Moreover, these treatments may be continued 335 after hospital discharge. These factors may be related to the emotional functioning, . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022 336 financial difficulties, and future uncertainty scores of the glioblastoma group.
337 However, within the scope of this study, we have not been able to examine the above 338 points, and they are only inferred.

340
A previous study in acute stroke patients reported a significant correlation between 341 the EQ-5D-5L index score and FIM motor items [32] and Barthel index [33]. In 342 contrast, a previous study of patients with brain tumors reported no correlation 343 between the total FIM score at discharge and the Functional Assessment of Cancer 344 Therapy-Brain (FACT-Br), a disease-specific HRQOL scale [18]. In the present 345 study, we also found a significant correlation between the FIM and EQ-5D-5L index 346 score. However, in the FIM total score and disease-specific HRQOL scale, the items 347 that showed significant correlations were limited to those related to physical function.
348 This finding was similar to those of previous studies, although the HRQOL scale 349 used was different. However, our results are noteworthy in that the EQ-5D-5L index 350 score and the disease-specific HRQOL scale showed significant correlations for all 351 items with the exception of headache, hair loss, and itchy skin on the BN20. Hirose 352 et al [29] reported a correlation between changes in adverse events and EQ-5D-5L 353 index scores in patients with cancer. In addition, the EQ-5D-3L index score of . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022 354 patients with brain tumors is reportedly associated with the emotional well-being 355 item of the FACT-Br [34] and anxiety and depression symptoms [35]. The 356 correlations between EQ-5D-5L index scores and the QLQ-C30 and BN20 in this 357 study were similar to those in previous studies, although the target diseases and 358 HRQOL assessment scales were different. Coomans et al [24] reported the impact of 359 HRQOL on OS in patients with gliomas, but the added value was low, indicating the 360 limitations of using HRQOL as a prognostic indicator of OS. However, Edelstein et 361 al [31] stated that the limitation of activity and participation due to glioblastoma is a 362 factor that interferes with subjective well-being and mentioned the possibility of 363 rehabilitation therapy to improve HRQOL. Similarly, in addition to training to 364 improve ADL as indicated by the HRQOL assessment, the importance of 365 rehabilitation treatment for patients with brain tumors, which is largely affected by 366 individual complaints, is demonstrated in this study.

367
368 Furthermore, we investigated the influence of factors such as brain tumor type, 369 surgery, radiotherapy, chemotherapy, and recurrence on the EQ-5D-5L index score.

370
The results of multiple regression analysis showed that glioblastoma and surgery 371 were the most influential factors. It has been reported that surgery in patients with . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
374 Furthermore, tumorectomy has been suggested to improve HRQOL by providing a 375 mass effect and improvement in hydrocephalus [22]. These previous findings support 376 the results of the present study that surgery was a factor in improving the EQ-5D-5L 377 index score. Vera et al [38] investigated the effect of different brain tumor 378 classifications on the EQ-5D-3L index score in patients with gliomas who were 379 undergoing outpatient treatment. After dividing the patients into two groups, grade 380 II/III and grade IV, we reported that the grade of the brain tumor was not a factor 381 affecting the EQ-5D-3L index score. Similar results were also reported in a study of 382 postoperative HGG and LGG patients [39]. In the present study, glioblastoma 383 reduced the EQ-5D-5L index score, and this finding differed from those of previous 384 studies. However, these previous studies were limited to the glioma population. In 385 our study, we used the EQ-5D-5L index and further divided the brain tumor 386 classifications into five groups, which we believe is a new finding.

388 Limitations
389 There are several limitations to this study. First, this study was conducted at a single . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022 390 institution and was limited to patients with brain tumors who underwent 391 rehabilitation treatment. In addition, patients with poor general health, cognitive 392 decline, or aphasia were excluded. Therefore, the results are not generalizable to all 393 patients with brain tumors. In addition, because this was a cross-sectional study, we 394 were not able to compare the findings before and after rehabilitation treatment, nor 395 were we able to examine changes after hospital discharge.
396 Second, brain tumor type may affect the choice of treatment for newly diagnosed and 397 recurrent brain tumors. In the PCNSL group, the main treatment was chemotherapy , affect HRQOL, but we were unable to 406 examine their effects in this study. In addition, the late effects of radiotherapy and 407 chemotherapy may have affected HRQOL after the study. Since brain tumors are rare, . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022 408 there is a need to evaluate a greater number of cases by conducting multicenter 409 studies. Furthermore, in the present study, the analysis was only performed at 410 discharge after rehabilitation therapy. We are currently conducting continuous 411 surveys before and after rehabilitation treatment and after discharge from the hospital 412 in order to longitudinally understand the effect of rehabilitation on ADL and 413 HRQOL.

415 Conclusion
416 This study investigated the HRQOL of patients with brain tumors who underwent 417 rehabilitation therapy and investigated the factors affecting the EQ-5D-5L index 418 score from various perspectives, including various brain tumor types, treatment 419 methods, and recurrence. In addition, we examined the relationship between the 420 EQ-5D-5L index score, disease-specific HRQOL scale, and FIM total score. The 421 EQ-5D-5L index score of the patients in this study was lower than that of the general 422 adult population. In addition, the glioblastoma group had the lowest EQ-5D-5L index 423 score among all brain tumor types. In addition, the EQ-5D-5L index score was 424 significantly correlated with most of the items of the disease-specific HRQOL scale 425 in addition to the total FIM score. Multiple regression analysis revealed that . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022.

461
Sequential bortezomib and temozolomide treatment promotes immunological . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 28, 2022.

533
population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 28, 2022.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 28, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022